MRVL

Marvell Technology, Inc.

68
Fundamentals84/ 100
Valuation31/ 100
Upside potential81/ 100
Risk potential22/ 100

MRVL offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.

TMUS

T-Mobile US, Inc.

69
Fundamentals60/ 100
Valuation82/ 100
Upside potential82/ 100
Risk potential9/ 100

TMUS has a slight edge over MRVL overall, supported by stronger valuation and lower modeled downside.

MRVL Fundamentals

MetricStatus
Strong
Healthy
Strong
Healthy

MRVL's revenue, profitability, cash flow and balance sheet are all currently healthy.

TMUS Fundamentals

MetricStatus
Stable
Healthy
Strong
Strong

TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.

MRVL PE Valuation

CHEAPFAIREXPENSIVE28x55x83x111x
CHEAPFAIREXPENSIVE28x55x83x111x
LevelPEPriceVs current
Cheap17x$51.02-69%
Fair25x$75.19-54%
Forward25x$164—
Current54x$164—
Expensive71x$215+31%

Historical ranges are pointers, not guarantees.

MRVL's PE is in its expensive range at 54x. If earnings grow as analysts expect, today's price would be 25x next year's earnings, in its fair range.

TMUS PE Valuation

CHEAPFAIREXPENSIVE32x65x97x130x
CHEAPFAIREXPENSIVE32x65x97x130x
LevelPEPriceVs current
Forward13x$171—
Current16x$171—
Cheap21x$218+27%
Fair26x$274+60%
Expensive56x$581+240%

Historical ranges are pointers, not guarantees.

TMUS has the edge over MRVL in the historical PE scenario, which offers more potential upside but is not a forecast.

MRVL Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Moderate

Analysts expect strong earnings and revenue growth for MRVL, with profitability improving.

TMUS Forward outlook

MetricOutlook
Strongly improving
Strong growth
Growth
Strongly improving
Limited
Moderate

Analysts expect earnings and revenue growth for TMUS, with profitability improving.

MRVL Risk to reward

ScenarioChangePrice
Upside+93%$316.61
Downside-22%$128.76

Calculated from the latest close: $164.45 on Nov 12.

MRVL trails TMUS on modeled risk to reward, with less potential upside relative to its potential downside.

TMUS Risk to reward

ScenarioChangePrice
Upside+41%$240.82
Downside-9%$155.85

Calculated from the latest close: $171.03 on Nov 12.

TMUS has a better modeled risk to reward balance than MRVL, with more potential upside relative to its potential downside.

MRVL Earnings Per Share

Q4 2023: $-0.65Q1 2024: $-1.08Q2 2024: $-1.13Q3 2024: $-1.11Q4 2024: $-1.70Q1 2025: $-1.02Q2 2025: $-0.57Q3 2025: $-0.13Q4 2025: $2.85Q1 2026: $3.07Q2 2026: $2.91Q3 2026: $3.02Forward: $6.51
Q4 2023: $-0.65Q1 2024: $-1.08Q2 2024: $-1.13Q3 2024: $-1.11Q4 2024: $-1.70Q1 2025: $-1.02Q2 2025: $-0.57Q3 2025: $-0.13Q4 2025: $2.85Q1 2026: $3.07Q2 2026: $2.91Q3 2026: $3.02Forward: $6.51
QuarterTTM EPSYoY
Forward$6.51+116%
Q3 2026$3.02+$3.15
Q2 2026$2.91+$3.48
Q1 2026$3.07+$4.09
Q4 2025$2.85+$4.55
Q3 2025-$0.13+$0.98
Q2 2025-$0.57+$0.56
Q1 2025-$1.02+$0.06
Q4 2024-$1.70-$1.05

MRVL has the edge over TMUS on earnings, with more consistent year-over-year improvement.

TMUS Earnings Per Share

Q4 2023: $6.93Q1 2024: $7.35Q2 2024: $7.98Q3 2024: $8.77Q4 2024: $9.66Q1 2025: $10.24Q2 2025: $10.59Q3 2025: $10.39Q4 2025: $9.72Q1 2026: $9.41Q2 2026: $9.56Q3 2026: $10.37Forward: $13.49
Q4 2023: $6.93Q1 2024: $7.35Q2 2024: $7.98Q3 2024: $8.77Q4 2024: $9.66Q1 2025: $10.24Q2 2025: $10.59Q3 2025: $10.39Q4 2025: $9.72Q1 2026: $9.41Q2 2026: $9.56Q3 2026: $10.37Forward: $13.49
QuarterTTM EPSYoY
Forward$13.49+30%
Q3 2026$10.37-0.2%
Q2 2026$9.56-9.7%
Q1 2026$9.41-8.1%
Q4 2025$9.72+0.6%
Q3 2025$10.39+18%
Q2 2025$10.59+33%
Q1 2025$10.24+39%
Q4 2024$9.66+39%

TMUS earned $10.37 per share over the past year, about the same as the year before.

MRVL Quarterly Revenue

Q4 2023: $1.4BQ1 2024: $1.4BQ2 2024: $1.2BQ3 2024: $1.3BQ4 2024: $1.5BQ1 2025: $1.8BQ2 2025: $1.9BQ3 2025: $2BQ4 2025: $2.1BQ1 2026: $2.2BQ2 2026: $2.4BQ3 2026: $2.7B
Q4 2023: $1.4BQ1 2024: $1.4BQ2 2024: $1.2BQ3 2024: $1.3BQ4 2024: $1.5BQ1 2025: $1.8BQ2 2025: $1.9BQ3 2025: $2BQ4 2025: $2.1BQ1 2026: $2.2BQ2 2026: $2.4BQ3 2026: $2.7B
QuarterRevenueYoY
Q3 2026$2.7B+37%
Q2 2026$2.4B+28%
Q1 2026$2.2B+22%
Q4 2025$2.1B+37%
Q3 2025$2B+58%
Q2 2025$1.9B+63%
Q1 2025$1.8B+27%
Q4 2024$1.5B+6.9%

MRVL has the edge over TMUS on sales, with stronger typical year-over-year growth.

TMUS Quarterly Revenue

Q4 2023: $20.5BQ1 2024: $19.6BQ2 2024: $19.8BQ3 2024: $20.2BQ4 2024: $21.9BQ1 2025: $20.9BQ2 2025: $21.1BQ3 2025: $22BQ4 2025: $24.3BQ1 2026: $23.1BQ2 2026: $22.8BQ3 2026: $23.6B
Q4 2023: $20.5BQ1 2024: $19.6BQ2 2024: $19.8BQ3 2024: $20.2BQ4 2024: $21.9BQ1 2025: $20.9BQ2 2025: $21.1BQ3 2025: $22BQ4 2025: $24.3BQ1 2026: $23.1BQ2 2026: $22.8BQ3 2026: $23.6B
QuarterRevenueYoY
Q3 2026$23.6B+7.4%
Q2 2026$22.8B+7.9%
Q1 2026$23.1B+11%
Q4 2025$24.3B+11%
Q3 2025$22B+8.9%
Q2 2025$21.1B+6.9%
Q1 2025$20.9B+6.6%
Q4 2024$21.9B+6.8%

TMUS's revenue has grown year over year for 10 quarters in a row: $23.6B last quarter, up 7.4% from the same quarter a year ago.

MRVL Free Cash Flow

Q4 2023: $449MQ1 2024: $476MQ2 2024: $233MQ3 2024: $258MQ4 2024: $461MQ1 2025: $444MQ2 2025: $214MQ3 2025: $414MQ4 2025: $509MQ1 2026: $259MQ2 2026: $483MQ3 2026: $479M
Q4 2023: $449MQ1 2024: $476MQ2 2024: $233MQ3 2024: $258MQ4 2024: $461MQ1 2025: $444MQ2 2025: $214MQ3 2025: $414MQ4 2025: $509MQ1 2026: $259MQ2 2026: $483MQ3 2026: $479M
QuarterFree cash flowYoY
Q3 2026$478.8M+16%
Q2 2026$483.1M+126%
Q1 2026$259.4M-42%
Q4 2025$508.8M+10%
Q3 2025$414.1M+60%
Q2 2025$214.1M-8.1%
Q1 2025$444.1M-6.6%
Q4 2024$461.3M+2.8%

MRVL generated $1.7B in free cash flow over the past year, up 13% from the year before.

TMUS Free Cash Flow

Q4 2023: $3.3BQ1 2024: $2.5BQ2 2024: $3.5BQ3 2024: $4.2BQ4 2024: $3.3BQ1 2025: $4.4BQ2 2025: $4.6BQ3 2025: $4.8BQ4 2025: $4.2BQ1 2026: $4.6BQ2 2026: $4.8BQ3 2026: $5.1B
Q4 2023: $3.3BQ1 2024: $2.5BQ2 2024: $3.5BQ3 2024: $4.2BQ4 2024: $3.3BQ1 2025: $4.4BQ2 2025: $4.6BQ3 2025: $4.8BQ4 2025: $4.2BQ1 2026: $4.6BQ2 2026: $4.8BQ3 2026: $5.1B
QuarterFree cash flowYoY
Q3 2026$5.1B+5.3%
Q2 2026$4.8B+4.4%
Q1 2026$4.6B+4.6%
Q4 2025$4.2B+25%
Q3 2025$4.8B+15%
Q2 2025$4.6B+32%
Q1 2025$4.4B+79%
Q4 2024$3.3B+2%

TMUS has the edge over MRVL on cash flow, with more consistent year-over-year improvement.

MRVL Total Shares

Q4 2023: 863MQ1 2024: 861MQ2 2024: 865MQ3 2024: 866MQ4 2024: 866MQ1 2025: 866MQ2 2025: 876MQ3 2025: 870MQ4 2025: 864MQ1 2026: 870MQ2 2026: 893MQ3 2026: 921M
Q4 2023: 863MQ1 2024: 861MQ2 2024: 865MQ3 2024: 866MQ4 2024: 866MQ1 2025: 866MQ2 2025: 876MQ3 2025: 870MQ4 2025: 864MQ1 2026: 870MQ2 2026: 893MQ3 2026: 921M
PeriodChange %Net change
Quarterly+3.1%+27.9M shares
1 year+5.8%+50.8M shares
3 years+7%+60.3M shares
5 years+12%+100M shares
Available history+38%+253M shares

MRVL has 921M diluted shares, up 5.8% from a year ago, despite $1.9B in buybacks over the past year.

TMUS Total Shares

Q4 2023: 1.2BQ1 2024: 1.2BQ2 2024: 1.2BQ3 2024: 1.2BQ4 2024: 1.2BQ1 2025: 1.1BQ2 2025: 1.1BQ3 2025: 1.1BQ4 2025: 1.1BQ1 2026: 1.1BQ2 2026: 1.1BQ3 2026: 1.1B
Q4 2023: 1.2BQ1 2024: 1.2BQ2 2024: 1.2BQ3 2024: 1.2BQ4 2024: 1.2BQ1 2025: 1.1BQ2 2025: 1.1BQ3 2025: 1.1BQ4 2025: 1.1BQ1 2026: 1.1BQ2 2026: 1.1BQ3 2026: 1.1B
PeriodChange %Net change
Quarterly-1%-10.8M shares
1 year-4.9%-55M shares
3 years-8.8%-103M shares
5 years-15%-182M shares
Available history+24%+207M shares

TMUS has the edge over MRVL on shareholder dilution, with a more favorable share count trend.

MRVL Net Leverage

QuarterNet LeverageStatus
Q1 20211.5xHealthy
Q4 20200.5xVery low
Q3 20200.6xVery low
Q2 20200.7xVery low
Q1 20200.7xVery low
Q4 20195.3xHigh

MRVL's net debt is about 1.5 years of its operating earnings (EBITDA), up from less than a year a year ago.

TMUS Net Leverage

Q4 2023: 2.6xQ1 2024: -0.1xQ2 2024: -0.0xQ3 2024: -0.1xQ4 2024: 2.4xQ1 2025: -0.1xQ2 2025: -0.1xQ3 2025: 0.1xQ4 2025: 2.5xQ1 2026: -0.0xQ2 2026: 0.1xQ3 2026: 0.0x
Q4 2023: 2.6xQ1 2024: -0.1xQ2 2024: -0.0xQ3 2024: -0.1xQ4 2024: 2.4xQ1 2025: -0.1xQ2 2025: -0.1xQ3 2025: 0.1xQ4 2025: 2.5xQ1 2026: -0.0xQ2 2026: 0.1xQ3 2026: 0.0x
QuarterNet LeverageStatus
Q3 20260.0xVery low
Q2 20260.1xVery low
Q1 2026-0.0xNet Cash
Q4 20252.5xModerate
Q3 20250.1xVery low
Q2 2025-0.1xNet Cash
Q1 2025-0.1xNet Cash
Q4 20242.4xModerate

TMUS's net debt is less than a year of its operating earnings (EBITDA).

MRVL Weekly Momentum

MetricValueStatus
RSI41.9Neutral
Stochastic16.1Oversold

MRVL's weekly RSI is 42 (neutral) and its Stochastic is 16 (oversold).

TMUS Weekly Momentum

MetricValueStatus
RSI47.9Neutral
Stochastic42.1Neutral

TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).

MRVL PE vs Technology Sector

MetricMRVLSector medianRelative
PE54x28x95% above
PE %753540 pts above

MRVL is trading at 54x earnings, a 95% premium to the Technology sector's median of 28x.

TMUS PE vs Communication Services Sector

MetricTMUSSector medianRelative
PE16x16xSame PE
PE %12625 pts below

TMUS has the edge over MRVL on valuation relative to its sector.

MRVL Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$221.026% below
20 week MA$220.926% below
50 week MA$168.82.5% below
100 week MA$124.832% above
200 week MA$93.875% above

MRVL has the edge over TMUS on trend strength, trading above more of its moving averages.

TMUS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$159.17.5% above
20 week MA$172.00.5% below
50 week MA$187.88.9% below
100 week MA$212.920% below
200 week MA$188.79.4% below

TMUS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 9.4% below its 200-week average.

MRVL Yearly ROI

YearStart priceEnd priceROI
2020$26.7$47.1+76%
2021$47.1$87.7+86%
2022$87.7$37.2-58%
2023$37.2$60.3+62%
2024$60.3$113.6+88%
2025$113.6$86.3-24%
2026 YTD$86.3$164.5+90%

MRVL has the edge over TMUS on returns for 2026, with the stronger performance.

TMUS Yearly ROI

YearStart priceEnd priceROI
2020$77.2$132.9+72%
2021$132.9$119.9-9.8%
2022$119.9$140.0+17%
2023$140.0$160.3+15%
2024$160.3$223.0+39%
2025$223.0$201.0-9.9%
2026 YTD$201.0$171.0-15%

TMUS has finished higher in four of the last six years. It's down 15% so far in 2026.

Give your agent the market.

Get API key